Trial Profile
A clinical pharmacological study of K-115 ophthalmic solution
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Kowa
- 19 Nov 2015 New trial record